CBRSCerebras Systems Inc.

Price: $103.97 | Today's Change: +6.36%

---

What Happened

Cerebras Systems Inc. filed its 10-Q for the third quarter of fiscal year 2026 with the SEC on November 12, 2026, revealing quarterly revenue of $338,548,000 — a figure that underscores the company's rapid commercial growth in AI compute infrastructure. Despite that top-line strength, the company reported a net loss of $23,867,000 and a substantially wider operating loss of $112,121,000 for the same period. Basic earnings per share came in at $1.92 while diluted EPS was $1.61, a discrepancy that reflects the impact of dilutive securities on the per-share calculation.

---

Why It Matters

For investors, this quarter presents a sharply bifurcated picture. On one hand, revenue of over $338 million demonstrates that Cerebras is successfully converting its AI chip and systems technology into real, large-scale customer contracts. On the other hand, the operating loss of more than $112 million signals that the cost structure of delivering that revenue — whether in the form of cost of goods, R&D spending, or operating overhead — remains extremely heavy relative to what flows to the bottom line. The gap between the operating loss ($112.1M) and the net loss ($23.9M) suggests that significant non-operating items, such as interest income, gains, or tax benefits, are meaningfully cushioning reported net income. Investors should scrutinize this wedge closely, as operating profitability remains elusive. With the stock up over 6% on the day of this report, the market appears to be reacting positively to the revenue scale, but the path to sustainable operating income is not yet visible in this filing's figures.

---

Analysis

The Q3 FY2026 results highlight a classic growth-stage tension for Cerebras: exceptional top-line momentum running directly into the high costs of competing in the AI semiconductor and systems market. A $338.5 million quarter is not trivial — it represents the kind of revenue run-rate that places Cerebras in a credible competitive conversation with larger, more established players in AI compute. However, an operating loss of $112.1 million on that same revenue base means operating margins remain deeply negative, a dynamic that investors following this space will recognize as an ongoing watchpoint.

The EPS figures deserve particular attention. Basic EPS of $1.92 and diluted EPS of $1.61 appear, at first glance, strikingly positive for a company reporting a net loss. This apparent contradiction is likely explained by the specific share count methodology and the classification of certain securities or adjustments in the XBRL-reported data — a nuance worth careful examination in the full filing text. Readers should not interpret these EPS figures as evidence of profitability without reviewing the complete income statement and share count disclosures in the 10-Q.

StockWatch's existing initiating coverage, published September 4, 2026, provides broader context for understanding Cerebras's strategic positioning — this quarterly filing adds a new data point to that framework. What to watch next: whether revenue growth is accelerating or stabilizing, the trajectory of operating expenses, and any commentary in the 10-Q's MD&A section on gross margin trends and customer concentration, particularly given Cerebras's known reliance on a small number of large customers in prior periods.

---

Disclaimer

This report is a news and informational analysis of a public SEC filing. It does not constitute investment advice, a recommendation to buy or sell any security, or a research rating of any kind. All financial figures cited are sourced exclusively from the company's official XBRL data as filed with the SEC. Investors should read the full 10-Q filing and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on CBRS, published 2026-09-04. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-12. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/2021728/000162828026073494/cbrs-20260930.htm